Case report reveals successful use of oral benzodiazepine for catatonia treatment amidst IV and IM shortages.
Catatonia is a clinical syndrome characterized by a constellation of psychomotor symptoms generally resulting in decreased functioning and responsiveness. Conventional catatonia management for stabilization and acute treatment recommends intravenous (IV) or intramuscular (IM) benzodiazepine administration; however, there is relatively limited literature with respect to the safety and efficacy of per os administration. Here, we present a case of an 18-year-old male with parakinetic catatonia successfully stabilized and treated using this less frequently documented method of administration to highlight alternatives amidst a national shortage of IV and IM lorazepam.
No takes yet. Share an insight, caveat, or question.
Atkinson et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: